9 Analysts Have This to Say About Merck & Co
Portfolio Pulse from Benzinga Insights
Over the last quarter, Merck & Co (NYSE:MRK) has received a mix of bullish and indifferent analyst ratings, with no bearish ratings. The average 12-month price target for the company, according to 9 analysts, is $125.11, which has increased by 10.72% over the past month.
October 04, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merck & Co has received a mix of bullish and indifferent analyst ratings, with an average 12-month price target of $125.11, which has increased by 10.72% over the past month.
The mix of bullish and indifferent ratings, along with the increase in the average 12-month price target, suggests a positive outlook for Merck & Co. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100